Related Experiment Videos
Panuveitis associated with multiple sclerosis complicated by cerebral venous thrombosis
Sibel Kadayifçilar1, Sansal Gedik, Bora Eldem
1Department of Ophthalmology, Hacettepe University School of Medicine, Ankara, Turkey. sibelk@hacettepe.edu.tr
Ocular Immunology and Inflammation
|October 30, 2004
Summary
Cerebral venous thrombosis is a rare complication of intravenous corticosteroid therapy for multiple sclerosis-associated uveitis. Close monitoring for systemic side effects is crucial during treatment.
Area of Science:
- Ophthalmology
- Neurology
- Immunology
Background:
- Multiple sclerosis (MS) is a chronic autoimmune disease affecting the central nervous system.
- Uveitis, particularly panuveitis and retinal perivasculitis, can be a manifestation of MS.
- Intravenous corticosteroid therapy is a common treatment for MS-related ocular inflammation.
Observation:
- A 44-year-old female patient with MS presented with panuveitis and retinal perivasculitis.
- She received three days of intravenous pulse corticosteroid therapy.
- Ocular inflammation showed improvement within a week of treatment initiation.
Findings:
- Ten days post-treatment, the patient developed cerebral venous thrombosis (CVT).
- This suggests a potential causal link between high-dose corticosteroids and CVT in this context.
- CVT is a serious neurological complication that requires prompt diagnosis and management.
Implications:
- This case highlights the importance of vigilance for CVT in MS patients undergoing high-dose corticosteroid treatment for uveitis.
- Physicians should consider CVT as a differential diagnosis in patients presenting with neurological symptoms after such therapy.
- Further research may be warranted to elucidate the precise mechanisms and risk factors for corticosteroid-induced CVT in MS patients.